GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: Cardiovascular outcomes and mortality benefits

Authors

Karldon Iwuchukwu Nwaezeapu
Godbless Ajenaghughrure
Ekow Essien, Advocate Health - MidwestFollow
Abena Agyekum

Recommended Citation

Nwaezeapu KI, Ajenaghughrure G, Essien E, Agyekum A. GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: Cardiovascular Outcomes and Mortality Benefits. American Heart Journal. 2025;290:9. doi:10.1016/j.ahj.2025.07.030

Type

Abstract